Xianjun Yu, MD, PhD
Fudan University
Emerging Leaders
not ranked
Current Leaders
#11427 pts
All-Time Leaders
#3373 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2019. 8 trials as lead/chair. How it works →
Trials led — by scientific impact
An Open Single-center Phase II Clinical Study of Fruquintinib Combined With Chemotherapy in Patients With Liver Metastases From Pancreatic Cancer
Phase 2UnknownFudan University
11
impact
Single-cell Sequencing and Establishment of Cell Lines, Organoids, and Transplanted Tumor Models in Neuroendocrine Neoplasm
N/AUnknownFudan University
9
impact
A Prospective Study of Plasma Cell-free DNA Fragmentomics for Early Detection of Pancreatic Neuroendocrine Tumors and Differential Diagnosis of Solid Pancreatic Tumors
N/ARecruitingFudan University
7
impact
Research on Neuroendocrine Neoplasm in a Single Center Based on Multi-omics Integrated Analysis
N/AUnknownXian-Jun Yu
7
impact
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer: An Multicenter Open-label Randomized Clinical Trial
N/AUnknownFudan University
6
impact
Long-term Prognosis Comparison Between Parenchyma-sparing and Oncologic Resections for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm: a Real-world Data Study
N/AUnknownFudan University
6
impact
Laparoscopic Radical Antegrade Modular Pancreatosplenectomy Versus Laparoscopic Distal Pancreatosplecnectomy in Selected Left-sided Pancreatic Cancer: a Multicenter Randomized Controlled Clinical Trial
N/ARecruitingFudan University
6
impact
Long-term Outcome in Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction: A Prospective Cohort Study
N/ACompletedFudan University
5
impact
Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy: A Multicenter Randomized Controlled Clinical Trial
N/ANot Yet RecruitingFudan University
4
impact
Factors Influencing the Occurrence of Pancreatic Fistula After Minimally Invasive Pancreatic Enucleation and Predictive Models: a Prospective Cohort Study
N/ACompletedFudan University
4
impact
An Open, Multicenter, Phase Ib/II Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection in Patients With Advanced Gastric/ Gastroesophageal Junction Adenocarcinoma and Pancreatic Cancer
Phase 2ActiveCARsgen Therapeutics Co., Ltd.
4
impact
An Open-label, Single-arm, Multicenter, Phase Ib Clinical Trial to Evaluate the Efficacy and Safety of CT041 Autologous CAR T Cell Injection After Adjuvant Chemotherapy in Subjects With Pancreatic Cancer
Phase 1RecruitingCARsgen Therapeutics Co., Ltd.
4
impact
A Phase Ib/II Study to Assess the Tolerability, Safety and Efficacy of Fluzoparib in Combination With mFOLFIRINOX Followed by Fluzoparib Maintenance Monotherapy in Patients With Advanced Pancreatic Cancer
Phase 2CompletedJiangsu HengRui Medicine Co., Ltd.
1
impact
A Randomized, Double-blind, Multi-center, Phase III Study of MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
Phase 3Not Yet RecruitingLepu Biopharma Co., Ltd.
0
impact
Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population（ProSight）: a Multi-centre Interventional Study
N/ANot Yet RecruitingShanghai Weihe Medical Laboratory Co., Ltd.
0
impact
A Phase Ⅱ Study of Chiauranib Plus Albumin-paclitaxel and Gemcitabine as First-line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2ActiveChipscreen Biosciences, Ltd.
0
impact
A Phase IB Study of Safety, Efficacy and Pharmacokinetic of Intravenously Administered Pelcitoclax (APG-1252) in Patients With Advanced Neuroendocrine Tumor
Phase 1TerminatedAscentage Pharma Group Inc.
0
impact